HomeIDIA • SWX
Idorsia Ltd
CHF 1.42
May 5, 10:05:00 PM GMT+2 · CHF · SWX · Disclaimer
StockCH listed security
Previous close
CHF 1.49
Day range
CHF 1.35 - CHF 1.50
Year range
CHF 0.61 - CHF 2.98
Market cap
320.81M CHF
Avg Volume
902.79K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF)Mar 2025Y/Y change
Revenue
58.88M485.38%
Operating expense
51.23M-24.02%
Net income
63.12M111.38%
Net profit margin
107.19-63.89%
Earnings per share
EBITDA
-17.91M80.07%
Effective tax rate
0.62%
Total assets
Total liabilities
(CHF)Mar 2025Y/Y change
Cash and short-term investments
64.85M-81.34%
Total assets
456.17M-41.56%
Total liabilities
1.59B-7.50%
Total equity
-1.13B
Shares outstanding
203.29M
Price to book
-0.27
Return on assets
-11.56%
Return on capital
-67.01%
Net change in cash
(CHF)Mar 2025Y/Y change
Net income
63.12M111.38%
Cash from operations
-60.67M48.71%
Cash from investing
6.86M-97.77%
Cash from financing
-1.65M
Net change in cash
-55.70M-129.35%
Free cash flow
-120.13M-349.05%
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Employees
938
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu